Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Norgine Ventures
AddedFeb 13, 2024
UpdatedJun 28, 2026
Norgine Ventures

Norgine Ventures

Operating

UK-based Norgine Ventures provides debt financing to innovative healthcare and life sciences companies globally.

Founded
2012
Firm
Compare
Portfolio
Employees
Website

Norgine Ventures, based in the United Kingdom, specializes in providing debt and debt-like financing to innovative, fast-growing companies in the healthcare and life sciences sectors across Europe and the US. Established in 2012, the firm leverages its affiliation with Norgine, a European healthcare company with over 110 years of experience. Norgine Ventures typically engages in Series A and other unspecified investment rounds, focusing on fostering innovation within its target industries.

Notable portfolio companies include Caresyntax and Imaginab, which have raised $11.9 million and $12.8 million respectively. The investment team at Norgine Ventures recently joined Hayfin Capital Management, enhancing their capabilities and reach. The firm benefits from Norgine's extensive technical expertise, offering a unique value-add to its portfolio companies by providing not just financial support but also strategic insights and industry-specific knowledge.

Norgine Ventures - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments2
Current Portfolio Count2
Total Portfolio Exits0

Top Investment Stages

Series A1 (50.0%)
Series Unknown1 (50.0%)

Stage Mix

Series A 50%Series Unknown 50%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Imaginab logo

Imaginab

Caresyntax logo

Caresyntax

Norgine Ventures - Similar Investment Firms

NextGen Ventures logo

NextGen Ventures

nextgenventures.nl

Novit Ventures logo

Novit Ventures

novitventures.com

Nesta Ventures logo

Nesta Ventures

nesta.org.uk

Innovestor logo

Innovestor

V-Bio Ventures logo

V-Bio Ventures

v-bio.ventures

EIR Ventures logo

EIR Ventures

eirventures.eu

Novartis Venture Fund logo

Novartis Venture Fund

nvfund.com

Ignite Innovation Fund logo

Ignite Innovation Fund

BioGeneration Ventures logo

BioGeneration Ventures

BGF Ventures logo

BGF Ventures

bgf.co.uk

Noria Capital logo

Noria Capital

Norwich Ventures logo

Norwich Ventures

Vesalius Biocapital Partners logo

Vesalius Biocapital Partners

NordicNinja logo

NordicNinja

Nordic Capital logo

Nordic Capital

nordiccapital.com

Norgine Ventures - Classification

NAICS
  • 520000Finance and Insurance
SIC
  • 6000Depository Institutions